Treatment of pain in sickle-cell crisis - To the editor Journal Article
| Authors: | Foley, K. M.; Portenoy, R. K. |
| Article Title: | Treatment of pain in sickle-cell crisis - To the editor |
| Abstract: | To the Editor: Griffin et al. (March 17 issue)1 report decreased duration of severe pain in children and adolescents with sickle cell disease after treatment with high-dose methylprednisolone. There are serious deficiencies in the methods used in this clinical study that arouse both scientific and ethical concern. Simply stated, the authors confuse the duration of analgesic use with analgesia. They describe the main analgesic outcome measures as the number of morphine doses used, the need for continuous morphine infusions, and the duration of opioid therapy. Only the data on duration were statistically significant. Despite an abundant literature on pain measurement. © 1994, Massachusetts Medical Society. All rights reserved. |
| Keywords: | adolescent; child; clinical trial; drug megadose; letter; pain; methylprednisolone; morphine; pain measurement; medical ethics; analgesia; corticotropin; anemia, sickle cell; hypophysis adrenal system; opiate agonist; human; priority journal; metyrapone; cortodoxone; sickle cell crisis |
| Journal Title: | New England Journal of Medicine |
| Volume: | 331 |
| Issue: | 5 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 1994-08-04 |
| Start Page: | 334 |
| Language: | English |
| DOI: | 10.1056/nejm199408043310518 |
| PUBMED: | 8068115 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | For original article, see PMID: 8107739, DOI: 10.1056/NEJM199403173301101 -- Export Date: 14 January 2019 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work